振东制药(300158.SZ)：累计回购1.29%股份 回购方案已实施完毕

Core Viewpoint - Zhen Dong Pharmaceutical (300158.SZ) has completed its share repurchase program, acquiring a total of 13,016,700 shares, which represents 1.29% of the company's total share capital, with a total expenditure of RMB 52,030,929 [1] Summary by Relevant Sections - Share Repurchase Details - The company repurchased shares through a dedicated securities account via centralized bidding [1] - The highest transaction price was RMB 10.06 per share, while the lowest was RMB 3.51 per share [1] - The repurchase program has now reached its deadline as of November 12, 2025, and has been fully implemented [1]